IT1127225B - 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione - Google Patents

5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione

Info

Publication number
IT1127225B
IT1127225B IT27284/79A IT2728479A IT1127225B IT 1127225 B IT1127225 B IT 1127225B IT 27284/79 A IT27284/79 A IT 27284/79A IT 2728479 A IT2728479 A IT 2728479A IT 1127225 B IT1127225 B IT 1127225B
Authority
IT
Italy
Prior art keywords
aminopyrimidines
imidazolin
replaced
preparation
replaced aminopyrimidines
Prior art date
Application number
IT27284/79A
Other languages
English (en)
Italian (it)
Other versions
IT7927284A0 (it
Inventor
Wolfgang Stenzel
Erich Cohnen
Wolfgang Fleck
Ben Armah
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2849537A external-priority patent/DE2849537C2/de
Priority claimed from DE19792937023 external-priority patent/DE2937023A1/de
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of IT7927284A0 publication Critical patent/IT7927284A0/it
Application granted granted Critical
Publication of IT1127225B publication Critical patent/IT1127225B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT27284/79A 1978-11-15 1979-11-14 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione IT1127225B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2849537A DE2849537C2 (de) 1978-11-15 1978-11-15 Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19792937023 DE2937023A1 (de) 1979-09-13 1979-09-13 Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
IT7927284A0 IT7927284A0 (it) 1979-11-14
IT1127225B true IT1127225B (it) 1986-05-21

Family

ID=25776489

Family Applications (1)

Application Number Title Priority Date Filing Date
IT27284/79A IT1127225B (it) 1978-11-15 1979-11-14 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione

Country Status (12)

Country Link
US (1) US4323570A (de)
AT (1) AT374197B (de)
AU (1) AU541305B1 (de)
CA (1) CA1138454A (de)
CH (1) CH642965A5 (de)
DK (1) DK150142C (de)
ES (1) ES486349A1 (de)
FR (1) FR2441625A1 (de)
GB (1) GB2039275B (de)
IT (1) IT1127225B (de)
NL (2) NL190553C (de)
SE (1) SE440079B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139477A3 (de) * 1983-09-23 1985-11-21 Eli Lilly And Company Verfahren zur Herstellung 5-substituierter Pyrimidine
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
DE3904795C2 (de) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmazeutisches Präparat und dessen Verwendung
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
US5972948A (en) * 1994-07-01 1999-10-26 Solvay Pharmaceuticals Gmbh Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
US5977121A (en) * 1995-02-28 1999-11-02 Eli Lilly And Company Use of moxonidine for the treatment of atherosclerosis
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
CA2182851A1 (en) * 1995-08-15 1997-02-16 August Masaru Watanabe Method for treating substance abuse withdrawal
KR20000016406A (ko) * 1996-06-06 2000-03-25 피터 지. 스트링거 울혈성 심장 마비 치료용 제제 및 방법_
CA2229123A1 (en) * 1997-02-11 1998-08-11 Mitchell Irvin Steinberg Pharmaceutical agents
DE19722322A1 (de) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephroprotektives Arzneimittel
AU9302298A (en) * 1997-09-03 1999-03-22 Eli Lilly And Company Pyrimidine derivatives
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
WO2004000312A2 (de) * 2002-06-19 2003-12-31 Solvay Pharmaceuticals Gmbh Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
CA2637292A1 (en) * 2006-01-27 2007-08-16 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of cns disorders
EP1894926A1 (de) * 2006-06-26 2008-03-05 Chemagis Ltd. Polymorphe von Moxonidine und Verfahren zu deren Herstellung
DE602006003204D1 (de) * 2006-06-26 2008-11-27 Chemagis Ltd Reinigungsverfahren von Moxonidine
EP1873151B1 (de) * 2006-06-26 2008-09-10 Chemagis Ltd. Verbessertes Verfahren zur Herstellung von Moxonidine
WO2008020425A1 (en) * 2006-08-17 2008-02-21 Chemagis Ltd. Crystalline moxonidine comprising single tautomer and preparation process therefor
DE602006018139D1 (de) * 2006-08-31 2010-12-23 Chemagis Ltd Verwendung der Monoxidinssalze zur Reinigung von Monoxidin
JP5167265B2 (ja) * 2006-10-19 2013-03-21 エフ.ホフマン−ラ ロシュ アーゲー 微量アミン関連受容体に親和性を有するアミノメチル−2−イミダゾール
AU2007312390B2 (en) * 2006-10-19 2013-03-28 F. Hoffmann-La Roche Ag Aminomethyl-4-imidazoles
CA2668454A1 (en) * 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles
WO2008058867A2 (en) * 2006-11-16 2008-05-22 F. Hoffmann-La Roche Ag Substituted 4-imidazoles
WO2008073125A1 (en) * 2006-12-12 2008-06-19 Chemagis Ltd. Moxonidine analogs, preparation processes and uses therefor
ES2364701T3 (es) * 2006-12-13 2011-09-12 F. Hoffmann-La Roche Ag Nuevos 2-imidazoles como ligandos para receptores asociados a aminas trazas.
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
EP2114906B1 (de) 2007-02-02 2014-08-06 F. Hoffmann-La Roche AG 2-aminooxazolinverbindungen als taar1-liganden für erkrankungen des zentralen nervensystems
CA2676944C (en) * 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
AU2008270444A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
CA2694362A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
CA2695071A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of cns disorders
AU2008285795A1 (en) * 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
RU2513086C2 (ru) * 2008-07-24 2014-04-20 Ф.Хоффманн-Ля Рош Аг Производные 4,5-дигидро-оксазол-2-ила
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
EP2586779A1 (de) 2011-10-24 2013-05-01 Hetero Research Foundation Verfahren zur Herstellung von Moxonidine
DE102012215896A1 (de) * 2012-09-07 2014-03-13 Wörwag Pharma GmbH & Co.KG Moxonidinsynthese mit Hilfe organischer Basen
EP2738165B1 (de) 2012-12-03 2016-10-12 WÖRWAG PHARMA GmbH & Co. KG Verfahren mittels Phasentransferkatalyse
EP2765131B1 (de) 2013-02-08 2016-11-23 Arevipharma GmbH Verfahren zur Herstellung von Moxonidin
EP2970214A1 (de) * 2013-03-14 2016-01-20 Farmak, A.S. Verbessertes verfahren zur herstellung von moxonidin
EP2829540A1 (de) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthese von substituierten Aminopyridinen
KR102456567B1 (ko) 2013-08-09 2022-10-19 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2017157873A1 (en) 2016-03-17 2017-09-21 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar
JP2023549394A (ja) 2020-11-12 2023-11-24 スリールセータ エーハゥーエッフ 注意欠陥/多動性障害の新規な治療
GB202103400D0 (en) * 2021-03-11 2021-04-28 3Z Ehf Novel treatments

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
GB1319840A (en) * 1970-08-27 1973-06-13 Beecham Group Ltd Substituted 5-amino imidazoles
BE795636A (fr) * 1972-02-19 1973-08-20 Schering Ag Nitroimidazolylpyrimidines, et leur procede de preparation
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
BE503170A (de) * 1975-09-02

Also Published As

Publication number Publication date
NL940011I1 (nl) 1994-08-01
AT374197B (de) 1984-03-26
NL940011I2 (nl) 1998-05-06
FR2441625B1 (de) 1981-12-31
FR2441625A1 (fr) 1980-06-13
GB2039275A (en) 1980-08-06
NL190553C (nl) 1994-04-18
DK150142B (da) 1986-12-15
CH642965A5 (de) 1984-05-15
SE440079B (sv) 1985-07-15
US4323570A (en) 1982-04-06
DK481879A (da) 1980-05-16
NL190553B (nl) 1993-11-16
IT7927284A0 (it) 1979-11-14
DK150142C (da) 1987-06-01
ES486349A1 (es) 1980-06-16
SE7909392L (sv) 1980-05-16
CA1138454A (en) 1982-12-28
ATA727079A (de) 1983-08-15
NL7908192A (nl) 1980-05-19
AU541305B1 (en) 1985-01-03
GB2039275B (en) 1982-11-17

Similar Documents

Publication Publication Date Title
IT1127225B (it) 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione
IT1112761B (it) Processo per la formazione di peci in neomesofase
IT1097652B (it) 17-alchilcarbonati di corticosteroidi e processo per la loro preparazione
IT1094039B (it) Processo per la preparazione di 2,2,6,6-tetrametil-4-piperidone
IT1096492B (it) Solfamoil-arilchetoni e processo per la loro preparazione
IT7949570A0 (it) Coloranti catiolici e procedimento per la loro produzione ed applicazione
IT1098396B (it) Fenileteri eterociclici e processo per la loro preparazione
BR7904057A (pt) Processo fisico-bioquimico
IT1098864B (it) Processo per la preparazione di nitroimidazoli
IT7927410A0 (it) Composizione e processo.
IT8021089A0 (it) Furani arilsostituiti e processo per la loro preparazione.
IT1094608B (it) Benzenesolfoniluree e processo per la loro preparazione
IT1101647B (it) Composti 1.8-naftiridinici e processo per la loro preparazione
IT7822440A0 (it) N-fenilformamidossime sostituite e processo per la loro preparazione.
IT1126432B (it) Esaidro-2,6-metano-3-benzazocine e processo di loro preparazione
BR7907758A (pt) Processo de preparacao de 2,3-dihidro-2,2-dimetil-7-hidroxi-benzofurano
IT1147347B (it) Cefalosporine e processo per la loro preparazione
IT1101646B (it) 4-carbeiossi-carbonilamino-pirimidine e processo per la loro preparazione
BR7900730A (pt) Composicao de derivados de 1,4-benzoazina e processo de sua preparacao
IT1075815B (it) Mezzi di rivestimento e processo per la loro preparazione
BR7902122A (pt) Processo integrado de amoniacoureia
IT1098203B (it) Cefalosporine e processo per la loro preparazione
IT1096405B (it) Composti azotati eterociclici e processo per la loro preparazione
IT1141073B (it) Processo per la preparazione di 3-(4-piridinil)-2-cicloesen-1-onossina
IT1193345B (it) Nuovi 3-idrossi-1,4-benzodiazepin-2-oni e processo per la loro preparazione

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971126